Beta-Amyloid (31-40)

(image for) Beta-Amyloid (31-40)
Product Name
Beta-Amyloid (31-40)
Product Quantity
5 mg
Catalog Number
LT8315
Molecular Weight
912.16
Formula
C44H82N10O11
Sequence
Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val, IIGLMVGGVV
Product Description

Beta-Amyloid (31-40), sequence IIGLMVGGVV, is a highly hydrophobic C-terminal fragment derived from the amyloid-β peptide associated with Alzheimer’s disease research. This segment corresponds to a portion of the transmembrane-facing hydrophobic domain of amyloid-β and plays an important role in peptide self-association, membrane interaction, and aggregation behavior.

The sequence contains multiple hydrophobic residues, including isoleucine, leucine, methionine, and valine, which contribute strongly to intermolecular interactions and amyloid assembly. Because of these physicochemical properties, the IIGLMVGGVV fragment is commonly used in studies examining amyloid aggregation, fibril nucleation, membrane insertion, and peptide secondary structure formation.

Research Background

The C-terminal hydrophobic region of amyloid-β is widely recognized as a major contributor to aggregation propensity and neurotoxic oligomer formation. Compared with N-terminal amyloid fragments, the C-terminal domain demonstrates significantly stronger hydrophobic interactions and plays a central role in stabilizing amyloid fibrils and oligomeric assemblies.

The IIGLMVGGVV fragment represents one of the most aggregation-prone regions within amyloid-β and has therefore been used as a simplified model system for studying hydrophobic peptide-driven self-assembly. Researchers frequently employ this fragment in biophysical studies to investigate amyloid nucleation mechanisms and peptide–membrane interactions without the complexity of the full-length peptide.

Applications in Alzheimer’s Disease and Amyloid Research

  • Amyloid aggregation and fibrillation studies
  • Hydrophobic peptide self-assembly research
  • Membrane interaction and insertion analysis
  • Secondary structure and β-sheet formation studies
  • Oligomerization and fibril nucleation assays
  • Biophysical characterization of amyloid domains

Membrane Interaction Studies

Because the IIGLMVGGVV sequence is strongly hydrophobic, it is frequently used in studies involving peptide–lipid interactions and membrane perturbation. The fragment has been investigated in model membrane systems, lipid vesicles, and bilayer studies to understand how amyloid peptides associate with cellular membranes and potentially contribute to membrane destabilization.

Hydrophobic amyloid segments such as IIGLMVGGVV are also relevant to studies examining peptide insertion into membrane-like environments and the formation of aggregation-prone conformations under physiologically relevant conditions.

Aggregation and Structural Studies

The peptide is useful for structural studies involving amyloidogenic peptides because its hydrophobic character strongly favors intermolecular association and β-sheet-rich assemblies. Researchers commonly analyze this fragment using circular dichroism (CD), NMR, FTIR, fluorescence spectroscopy, and electron microscopy techniques.

This fragment may also serve as a model sequence for investigating how small molecules, metals, surfactants, or peptide modifications influence amyloid aggregation behavior.

Why Use Aβ (31-40)?

  • Represents a key hydrophobic region of amyloid-β
  • Strong aggregation and self-assembly behavior
  • Useful for membrane interaction studies
  • Relevant to amyloid fibril and oligomer formation research
  • Simplified model system for hydrophobic amyloid domains

Solubility and Handling Notes

Due to its highly hydrophobic nature, IIGLMVGGVV may exhibit limited aqueous solubility and aggregation tendency. Researchers often dissolve the peptide in DMSO, HFIP, or other suitable organic solvents prior to dilution into aqueous buffers depending on the intended experimental protocol.

For additional information on amyloid peptide handling and solubilization strategies, please see:

Amyloid Peptides for Alzheimer’s Disease Research
Peptide Solubilization – Amyloids Case Study (PDF)

Related Products

Beta-Amyloid (1-42), human
Beta-Amyloid (1-40), Ultra Pure, TFA
Amyloid peptide category
Amyloid Peptides for Alzheimer’s Disease Research

Research Use Only. Not for human or therapeutic use.

Scientific Background

Beta-Amyloid (31-40) is a synthetic amyloid-beta (Aβ) research peptide. Amyloid-beta peptides are proteolytic products of amyloid precursor protein. Sequence length and residue composition strongly influence aggregation: Aβ42 generally aggregates more rapidly than Aβ40, and C-terminal fragments containing residues in the 34-42 region can adopt stable beta-structure. Truncated, reverse-sequence, isotopically labeled, or chemically modified Aβ constructs are therefore best interpreted as distinct research reagents rather than assumed equivalents of native Aβ40 or Aβ42.

Research Applications
  • amyloid aggregation and fibrillization studies
  • LC-MS/HPLC analytical reference work
  • Aβ sequence-length and modification comparisons
  • antibody, binding, and assay controls
Experimental Notes

The exact sequence, phosphorylation state, residue numbering, terminal modifications, labels, and species context should be matched to the intended assay. Sequence motifs support experimental interpretation but do not by themselves establish absolute enzyme specificity or native biological activity.

Selected References
  1. Sequence determinants of enhanced amyloidogenicity of Aβ42 relative to Aβ40
  2. Molecular determinants of amyloid deposition: synthetic beta-protein fragments
  3. Impact of sequence on assembly of short amyloid peptides
  • 6 Units in Stock
Ask a Question

$350.00

Add to Cart: